CBDL

Healthcare Drug Manufacturers - Specialty & Generic

CBD Life Sciences Inc.

$0.00

-0.00 -50.00% today

Price History

Not enough data

Key Stats

Market Cap

611,057

Avg Volume

3.23M

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/S Ratio

6.21

EV/Revenue

6.95

Margins

Gross Margin 42.2%

Operating Margin (94.9%)

Net Margin (49.8%)

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

143.6%

Return on Equity

(8.7%)

Return on Assets

(10.8%)

Liquidity & Leverage

Current Ratio

15.12

Quick Ratio

14.21

Total Cash

331,598

Total Debt

About

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.